Ignite Creation Date:
2025-12-25 @ 1:59 AM
Ignite Modification Date:
2025-12-26 @ 4:38 AM
Study NCT ID:
NCT00727194
Status:
TERMINATED
Last Update Posted:
2019-09-24
First Post:
2008-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-30
First Submit QC Date:
None
Study First Post Date:
2008-08-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-22
Results First Submit QC Date:
None
Results First Post Date:
2016-12-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-13
Last Update Post Date:
2019-09-24
Last Update Post Date Type:
ACTUAL